Cargando…

Molecular Modeling of the HR2 and Transmembrane Domains of the SARS-CoV-2 S Protein in the Prefusion State

SARS-CoV-2, the causative agent of COVID-19, remains the focus of research worldwide. SARS-CoV-2 entry into the cell starts with its S protein binding to the angiotensin-converting enzyme-2 (ACE2) expressed on the cell surface. The knowledge of the S protein’s spatial structure is indispensable for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bozdaganyan, M. E., Orekhov, P. S., Litvinov, D. S., Novoseletsky, V. N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pleiades Publishing 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517943/ https://www.ncbi.nlm.nih.gov/pubmed/34667336 http://dx.doi.org/10.3103/S0096392521030044

Ejemplares similares

Dynamics of SARS-coronavirus HR2 domain in the prefusion and transition states
por: McReynolds, Susanna, et al.
Publicado: (2009)

Computational Analysis of Mutations in the Receptor-Binding Domain of SARS-CoV-2 Spike and Their Effects on Antibody Binding
por: Bozdaganyan, Marine E., et al.
Publicado: (2022)

Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike
por: Huo, Jiandong, et al.
Publicado: (2020)

Immune Escape Associated with RBD Omicron Mutations and SARS-CoV-2 Evolution Dynamics
por: Kudriavtsev, Aleksandr V., et al.
Publicado: (2022)

Continuous flexibility analysis of SARS-CoV-2 spike prefusion structures
por: Melero, Roberto, et al.
Publicado: (2020)

Structure-based design of prefusion-stabilized SARS-CoV-2 spikes
por: Hsieh, Ching-Lin, et al.
Publicado: (2020)

Structure-based Design of Prefusion-stabilized SARS-CoV-2 Spikes
por: Hsieh, Ching-Lin, et al.
Publicado: (2020)

Continuous flexibility analysis of SARS-CoV-2 Spike prefusion structures
por: Melero, Roberto, et al.
Publicado: (2020)

Prefusion spike protein conformational changes are slower in SARS-CoV-2 than in SARS-CoV-1
por: Govind Kumar, Vivek, et al.
Publicado: (2022)

Structural dynamics of prefusion spike protein of SARS-CoV-2 and its variants
por: Derakhshani-Molayousefi, Mortaza, et al.
Publicado: (2022)

High-throughput identification of prefusion-stabilizing mutations in SARS-CoV-2 spike
por: Tan, Timothy J.C., et al.
Publicado: (2022)

High-throughput identification of prefusion-stabilizing mutations in SARS-CoV-2 spike
por: Tan, Timothy J. C., et al.
Publicado: (2023)

CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challenge
por: Lien, Chia-En, et al.
Publicado: (2021)

Enhancing the Prefusion Conformational Stability of SARS-CoV-2 Spike Protein Through Structure-Guided Design
por: Riley, Timothy P., et al.
Publicado: (2021)

Dimerized fusion inhibitor peptides targeting the HR1–HR2 interaction of SARS-CoV-2
por: Tsuji, Kohei, et al.
Publicado: (2023)

Secondary Structures of the Transmembrane Domain of SARS-CoV-2 Spike Protein in Detergent Micelles
por: Li, Qingxin, et al.
Publicado: (2022)

A Uniquely Stable Trimeric Model of SARS-CoV-2 Spike Transmembrane Domain
por: Aliper, Elena T., et al.
Publicado: (2022)

Human Monoclonal Antibodies against Highly Conserved HR1 and HR2 Domains of the SARS-CoV Spike Protein Are More Broadly Neutralizing
por: Elshabrawy, Hatem A., et al.
Publicado: (2012)

Viral Prefusion Targeting Using Entry Inhibitor Peptides: The Case of SARS-CoV-2 and Influenza A virus
por: Behzadipour, Yasaman, et al.
Publicado: (2022)

Virtual Screening of Phytochemicals by Targeting HR1 Domain of SARS-CoV-2 S Protein: Molecular Docking, Molecular Dynamics Simulations, and DFT Studies
por: Majeed, Arshia, et al.
Publicado: (2021)

Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers
por: Mandala, Venkata S., et al.
Publicado: (2020)

The Interaction of the Transmembrane Domain of SARS-CoV-2 E-Protein with Glycyrrhizic Acid in Lipid Bilayer
por: Kononova, Polina A., et al.
Publicado: (2023)

A variant-proof SARS-CoV-2 vaccine targeting HR1 domain in S2 subunit of spike protein
por: Pang, Wei, et al.
Publicado: (2022)

HR121 targeting HR2 domain in S2 subunit of spike protein can serve as a broad-spectrum SARS-CoV-2 inhibitor via intranasal administration
por: Lu, Ying, et al.
Publicado: (2023)

Targeting the SARS-CoV-2 spike glycoprotein prefusion conformation: virtual screening and molecular dynamics simulations applied to the identification of potential fusion inhibitors
por: Romeo, Alice, et al.
Publicado: (2020)

A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spike
por: Lu, Mijia, et al.
Publicado: (2021)

Architecture of the SARS coronavirus prefusion spike
por: Beniac, Daniel R, et al.
Publicado: (2006)

Synergistic Effect of Chemical Penetration Enhancers on Lidocaine Permeability Revealed by Coarse-Grained Molecular Dynamics Simulations
por: Bozdaganyan, Marine E., et al.
Publicado: (2021)

Solution Structure of the Severe Acute Respiratory Syndrome-Coronavirus Heptad Repeat 2 Domain in the Prefusion State
por: Hakansson-McReynolds, Susanna, et al.
Publicado: (2006)

Intricacies of the SARS-CoV-2 spike transmembrane trimer organization
por: Aliper, Elena T., et al.
Publicado: (2022)

Dimeric Transmembrane Structure of the SARS-CoV-2 E Protein
por: Zhang, Rongfu, et al.
Publicado: (2023)

Dimeric Transmembrane Structure of the SARS-CoV-2 E Protein
por: Zhang, Rongfu, et al.
Publicado: (2023)

Newcastle Disease Virus-Like Particles Displaying Prefusion-Stabilized SARS-CoV-2 Spikes Elicit Potent Neutralizing Responses
por: Yang, Yongping, et al.
Publicado: (2021)

ChAdOx1 COVID vaccines express RBD open prefusion SARS-CoV-2 spikes on the cell surface
por: Ni, Tao, et al.
Publicado: (2023)

Abstract 1510: Synthesis and Analysis of the SARS-CoV-2 ORF7a Accessory Protein Transmembrane Domain and Determination of the Oligomerization State
por: Hobart, Tyler, et al.
Publicado: (2023)

Implications for SARS-CoV-2 Vaccine Design: Fusion of Spike Glycoprotein Transmembrane Domain to Receptor-Binding Domain Induces Trimerization
por: Azad, Taha, et al.
Publicado: (2020)

Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19
por: Kuo, Tsun-Yung, et al.
Publicado: (2020)

An alphavirus replicon particle delivering prefusion-stabilized spike protein provides potent immunoprotection against SARS-CoV-2 Omicron variant
por: Zhang, Hong-Qing, et al.
Publicado: (2022)

Deletion of BST2 Cytoplasmic and Transmembrane N-Terminal Domains Results in SARS-CoV, SARS-CoV-2, and Influenza Virus Production Suppression in a Vero Cell Line
por: Dolskiy, Alexander A., et al.
Publicado: (2020)

Targeting the SARS-CoV-2 HR1 with Small Molecules as Inhibitors of the Fusion Process
por: Gentile, Davide, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7npgfp26e3mifj39i2mrd0u54v